Erica Da Pian Appointed US Marketing Manager for PQE Group
Erica Da Pian Appointed US Marketing Manager for PQE Group
5 Questions With Joshua Taylor, MS, MBA, PMP, Technical Sales Specialist – Cell and Gene Therapy, BioIVT
5 Questions With Joshua Taylor, MS, MBA, PMP, Technical Sales Specialist – Cell and Gene Therapy, BioIVT 1. What did you want to be when you grew up? How’d you [….]
Ted Ajmo, Ph.D. Hired as Associate at McBee Moore & Vanik IP, LLC
Ted Ajmo, Ph.D. Hired as Associate at McBee Moore & Vanik IP, LLC
These Maryland Tech, Ed and Industry Leaders Are TEDCO’s Newest Board Officers
Three leaders of premiere Maryland educational institutions (two in Baltimore, one south of DC) join an ex-IBM executive and consultancy president to lead the State of Maryland-connected funding entity TEDCO’s board of directors.
TEDCO announced its latest slate of board officers earlier this week, following a virtual election that took place at TEDCO’s Sept. 15 board meeting — the same date the new officers’ tenure took effect.
A statement noted that Omar S. Muhammad, the director of Morgan State University’s Entrepreneurial Development and Assistance Center, will return to chair the board for a second year. His election last year made him the first Black professional to lead TEDCO’s board in its near-quarter-century of existence.
American Gene Technologies® Welcomes Barry H. Wells, M.D., as Head of Business Development
American Gene Technologies, a clinical-stage biotechnology company based in Rockville, Maryland, has promoted Barry H. Wells, M.D. as head of business development. Dr. Wells joined the company’s investor relations team in 2019.
Prince William County Hires New Life Sciences Business Development Manager
Prince William County Department of Economic Development (PWCDED) hired Helena Kondow-McConaghy, Ph.D. as Business Development Manager for the Life Sciences to recruit and retain businesses in the fastest growing biotechnology cluster in the Greater Washington, D.C. region.
Deka Biosciences Appoints Chief Medical Officer and Vice President of Clinical Operations
Deka Biosciences (“Deka”), a biotech company focused on the development of novel cytokine therapies to treat cancer and inflammatory diseases, announced today the appointment of Charlotte Moser, MD, PhD, MSc, MBA as Chief Medical Officer (CMO) and Deb Kientop, MBA as Vice President, Clinical Operations.